Department of Otolaryngology, Hospital Universitario Central de Asturias-University of Oviedo, Oviedo, Asturias, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, IUOPA, CIBERONC, Oviedo, Asturias, Spain.
Adv Ther. 2020 Jul;37(7):3112-3128. doi: 10.1007/s12325-020-01391-1. Epub 2020 Jun 1.
Aggressive variants of papillary thyroid cancer (PTC) have been described with increasing frequency. These variants include diffuse sclerosing variant, tall cell variant, columnar cell variant, solid variant, and hobnail variant.
We have performed a review of the more aggressive variants of PTC with respect to main characteristics, histological and molecular features, and the consequences that the knowledge of these variants should have in the treatment of the patients.
At the present time, we do not know the prognostic value of these aggressive PTC variants. The extent of the surgical treatment and adjuvant therapy necessary should be decided on the basis of the extent of the tumor at presentation and the opinion of experienced clinicians.
These aggressive variants should be known by clinicians, to avoid underdiagnosis, and treated according to the latest recommendations in the literature.
具有侵袭性的甲状腺乳头状癌(PTC)变体越来越频繁地被描述。这些变体包括弥漫硬化型、高细胞型、柱状细胞型、实体型和鞋钉型。
我们对侵袭性更强的 PTC 变体进行了综述,涉及主要特征、组织学和分子特征,以及了解这些变体对患者治疗应产生的影响。
目前,我们尚不清楚这些侵袭性 PTC 变体的预后价值。手术治疗和辅助治疗的范围应根据肿瘤的程度和经验丰富的临床医生的意见来决定。
临床医生应该了解这些侵袭性变体,以避免漏诊,并根据文献中的最新建议进行治疗。